September 29, 2020 11:19 AM EDTUpdated 11:40 AM
News Briefing

News brief­ing: PhI­II Alzheimer's play draws an­oth­er $33M+; Ar­ran­ta un­veils $100M+ mi­cro­bio­me man­u­fac­tur­ing site

Amber Tong

More mon­ey is flow­ing to­wards the dis­as­ter-prone yet high­ly sought af­ter quest for an Alzheimer’s dis­ease treat­ment. To­day, it is AZTher­a­pies’s turn to rake it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times